IMDx VanR Assay for Abbott MDx System Cleared in Canada, Singapore | GenomeWeb

NEW YORK (GenomeWeb News) — IMDx said today that its IMDx VanR assay for the Abbott m2000 platform has received regulatory clearance from Health Canada and Singapore's Health Sciences Authority, allowing the test to be sold and distributed in those countries.

The assay detects the presence of vanA and vanB genes that can be associated with vancomycin-resistant enterococci. It is intended to be used as an aid to identify, prevent, and control vancomycin-resistant colonization in healthcare settings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.